Stock Chart

TEVA

$34.08 +3.05%
Score: 54.0 HOLD
1Y Target $33.50 -1.7%
i
1Y Price Target

This target is derived from long-term trendline analysis and projected growth.

Note: Targets are based on the assumption that the current primary trend continues. They should be used as reference points, not guarantees.

Target may adjust dynamically as the stock trend reverses or accelerates.
LEAPs: SELL $37
i
LEAPs Option Signal

Type: SELL growth_1yr
Strike: $37
Premium: $1.99
Expiry: Jan 15, 2027
Target: $32
Score: -100

LEAPs are long-term options (1+ year) with less time decay.
30D Target: $38.94 - $39.58 STRONG_UPTREND
i
30D Trendline Target

This is a PROJECTED price range based on extrapolating the current trendline slope forward 30 days.

How it works:
• Draws support and resistance trendlines
• Calculates slope (rate of change)
• Projects lines to 30 days future

Signals:
● STRONG_UPTREND: Steep rise
● UPTREND: Moderate rise
● SIDEWAYS: Flat/Mixed
● DOWNTREND: Falling

⚠️ Not a prediction. Shows trend projection only.

R-squared: 0.92
Vol: 1.61x (vs SPY: 1.3x | vs QQQ: 1.3x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Technical Chart
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About TEVA - Teva Pharmaceutical Industries Limited American Depositary Shares

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar …

Key Statistics

Market Cap $37B
P/E Ratio 26.74

This TEVA stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track TEVA's price movements with trendlines, gamma walls, and key support/resistance levels.